시장보고서
상품코드
1429599

세계의 의약품 API 제조 시장 보고서(2024년)

Pharmaceutical API Manufacturing Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

의약품 API 제조 시장 규모는 향후 몇 년 동안 크게 성장할 것으로 예상됩니다. 2028년에는 6.2%의 연평균 복합 성장률(CAGR)로 2,790억 3,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 인구 고령화 증가, 기술의 급속한 발전, 암 발병률 증가, 인수합병 증가, 신흥국의 높은 잠재력 등이 성장을 촉진할 것으로 보입니다. 예측 기간의 주요 동향으로는 생산 시설의 확장, 인공지능(AI) 사용, 친환경 API 제조에 대한 집중, 투자 증가 및 QR 코드 라벨 사용에 대한 집중 등이 있습니다.

고령화 인구의 증가는 의약품 API 제조 시장의 중요한 원동력입니다. 고령화가 진행됨에 따라 의약품에 대한 수요도 증가하고 있습니다. API는 이러한 의약품에서 중요한 역할을 하며 특정 질병을 치료하기 위한 전문 의약품 역할을 합니다. 예를 들어, 2022년 10월 세계보건기구(WHO)가 공유한 기사에 따르면, 2050년까지 노인 인구의 80%가 저소득 및 중저소득 국가에 거주할 것으로 예상됩니다. 고령화 인구는 전 세계 인구보다 빠른 속도로 증가하고 있습니다. 과거와 마찬가지로 2020년에는 60세 이상 인구가 5세 미만 인구보다 더 많을 것으로 예상됩니다. 따라서 고령화 인구의 증가는 의약품 API 제조 시장을 주도하는 중요한 요인이 될 것입니다.

만성질환의 급증은 향후 의약품 API 제조 시장을 견인할 것으로 예상됩니다. 만성 증상 또는 만성 질환은 장기간, 종종 평생 동안 지속되는 장기적인 건강 상태이며 일반적으로 완전히 치료할 수없는 장기적인 건강 상태입니다. 의약품의 품질, 효능 및 안전성은 사용되는 API에 따라 크게 좌우됩니다. 의약품 API 제조는 만성질환 관리에 필수적인 의약품 생산에 중요한 역할을 합니다. 예를 들어, 2023년 국립의학도서관에 따르면 2035년까지 50세 이상 미국 성인의 약 36%가 적어도 한 가지 이상의 만성질환을 앓을 것으로 예상되며, 이 수치는 2050년까지 거의 48%까지 증가할 것으로 예측됩니다. 따라서 만성 질환의 증가는 의약품 API 제조 시장의 원동력이 될 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 의약품 API 제조 시장, 치료 분야별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 심혈관장애
  • 대사장애
  • 신경학적 장애
  • 종양학
  • 근골격계 질환
  • NSAID
  • 기타 치료 용도
  • 세계의 의약품 API 제조 시장, API 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 화학 API
  • 생물학 API
  • 세계의 의약품 API 제조 시장, 의약품 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 처방약
  • 시판약(OTC)

제7장 지역 및 국가 분석

  • 세계의 의약품 API 제조 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 의약품 API 제조 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 의약품 API 제조 시장 경쟁 상황
  • 의약품 API 제조 시장 기업 개요
    • Pfizer Inc
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Dr. Reddy's Laboratories

제31장 기타 주요 및 혁신적인 기업

  • BASF SE
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Lupin Ltd
  • Cipla Inc.
  • Arlak Biotech
  • Healthkind Labs Pvt. Ltd
  • SwisscheM Healthcare Pvt. Ltd
  • Apikos Pharma
  • Kolaz Biotech
  • CStone Pharma
  • CARsgen Therapeutics
  • JW Therapeutics
  • BeiGene
  • Takeda Pharmaceuticals

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

The manufacturing of pharmaceutical active pharmaceutical ingredients (API) involves producing the active substances that impart the desired impact on the body for the treatment of a specific condition in pharmaceutical medicines. To create APIs, chemical components undergo processing. The active component of a biological drug is termed a bulk process intermediate.

pharmaceutical API manufacturing focuses on various therapy areas, including cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, and other therapeutic uses. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels. Chemical API and biological API are the primary types used in the production of innovative drugs, generic prescription drugs, and over-the-counter (OTC) drugs.

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical active pharmaceutical ingredients (API) manufacturing market statistics, including pharmaceutical active pharmaceutical ingredients (API) manufacturing industry global market size, regional shares, competitors with a pharmaceutical active pharmaceutical ingredient (API) manufacturing market share, detailed pharmaceutical active pharmaceutical ingredients (API) manufacturing market segments, pharmaceutical active pharmaceutical ingredients (API) manufacturing market trends and opportunities, and any further data you may need to thrive in the pharmaceutical active pharmaceutical ingredients (API) manufacturing industry. The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical API manufacturing market size has grown strongly in recent years. It will grow from $206.95 billion in 2023 to $219.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%.The growth in the historical period can be attributed to an increase in research and development (R&D) expenditure in the pharmaceutical sector, a growing preference for outsourcing active pharmaceutical ingredients (APIs), a rise in the prevalence of chronic illnesses, increased healthcare expenditure, a growth in disposable income, an increase in patent expiration, and the implementation of government policies promoting API production.

The pharmaceutical API manufacturing market size is expected to see strong growth in the next few years. It will grow to $279.03 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the increasing aging population, rapid advancements in technology, a rising prevalence of cancer, increasing mergers and acquisitions, and the high potential of emerging economies, all of which will drive growth. Major trends in the forecast period include a focus on expanding production facilities, the use of artificial intelligence (AI), emphasis on greener API manufacturing, and increased investments and focus on the use of QR code labeling.

The increase in the aging population is a significant driver of the pharmaceutical API manufacturing market. With the rise in the aging population, there is a corresponding increase in the demand for pharmaceutical drugs. APIs play a crucial role in these medicines, serving as specialty drugs to address specific diseases. For example, an article shared by the World Health Organization (WHO) in October 2022 revealed that 80% of senior citizens are projected to reside in low- and middle-income nations by 2050. The aging population is growing at a faster rate than in the past, with more individuals over the age of 60 than under five-year-olds projected for 2020. Therefore, the growth of the aging population is a key factor driving the pharmaceutical API manufacturing market.

The surge in chronic conditions is anticipated to drive the pharmaceutical API manufacturing market in the future. Chronic conditions, or chronic diseases, are long-term health conditions that persist for extended periods, often throughout a person's lifetime, and typically cannot be completely cured. The quality, effectiveness, and safety of medications depend significantly on the API used. pharmaceutical API manufacturing plays a crucial role in producing essential medications for managing chronic diseases. For instance, according to the National Library of Medicine in 2023, it is projected that nearly 36% of US adults aged 50 and older will have at least one chronic condition by 2035, with this number expected to rise to almost 48% by 2050. Therefore, the increase in chronic conditions is a driving force for the pharmaceutical API manufacturing market.

Many companies leverage modern technologies such as process control and powder handling to optimize the manufacturing of Active Pharmaceutical Ingredients (API). These technologies include advancements in Lyophilization, a freeze-drying process involving low-temperature dehydration by freezing the product, lowering pressure, and removing the formed ice. For example, Telstar, a company specializing in efficient integrated systems for pharmaceutical and manufacturing processes, introduced LyoGistics Zero-an automatic loading and unloading system for freeze dryers designed for hazardous products. The system utilizes a linear magnetic driving mechanism, eliminating racks and belts to reduce particle generation and enhance hygiene in API manufacturing. Additionally, ILC Dover, a pharmaceutical company, developed the JetBreaker system, a semi-automatic powder handling system that separates powdered media and buffers powders to improve their mixing in a solution.

Key companies in the pharmaceutical API manufacturing market are dedicated to developing innovative solutions such as Apisolex to streamline manufacturing processes and minimize API loss. Apisolex, launched by Lubrizol Life Science (LLS) Health in March 2022, is a novel solubility-enhancing excipient technology addressing solubility challenges. It can significantly enhance solubility, support high drug loading, and optimize manufacturing efficiency by reducing API loss and ensuring efficient encapsulation.

In March 2021, Piramal Pharma Ltd., an India-based healthcare solutions company, acquired Hemmo Pharmaceuticals for $105.8 million. This strategic acquisition is poised to expand PPS's capacity to offer integrated services globally, providing access to the growing peptide API industry. The deal is expected to augment peptide API manufacturing and development capabilities. Hemmo Pharmaceuticals, based in India, specializes in the development and manufacturing of peptide APIs.

Major companies operating in the pharmaceutical API manufacturing market report are Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, BASF SE, Sun Pharmaceutical Industries Ltd., Novartis AG, Lupin Ltd., Cipla Inc., Arlak Biotech, Healthkind Labs Pvt. Ltd., SwisscheM Healthcare Pvt. Ltd., Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc., Otsuka Pharmaceutical Co, Ltd., Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical, Sankyo, GlaxoSmithKline (GSK), AstraZeneca, Abbott Laboratories, Vectura Group, Roche Holding AG, Merck & Co, Boehringer Ingelheim, Zentiva, Microgen, Geropharm, Valenta, NovaMedica, Veropharm, Celon Pharma, SynBio, Generium, Skopinpharm, ALMEDIS, Biocad, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, Mylan, BioVectra, Celgene Corporation, Kashiv Pharma, Cambrex, Eli Lilly and Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, AbbVie Inc., Hisun USA Inc., AMEGA Biotech, BioMarin Pharmaceutical, Ferring Pharmaceuticals, Tikun Olam Cannbit, Wavelength Pharmaceuticals, SAUDIBIO, Tabuk Pharmaceuticals, Bayer, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd., Aspen

North America was the largest region in the pharmaceutical API manufacturing market in 2023. The Middle East is expected to be the fastest-growing region in the global pharmaceutical API manufacturing market share during the forecast period. The regions covered in the pharmaceutical API manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical API manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market includes tablets, capsules, creams, and injectable sales. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical API Manufacturing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical api manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical api manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical api manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Therapy Area: Cardiovascular Disorders; Metabolic Disorders; Neurological Disorders; Oncology; Musculoskeletal Disorders; Other Therapeutics Uses
  • 2) By API Type: Chemical API; Biological API
  • 3) By Drug Type: Prescription Drugs; Over-The-Counter (OTC) Drugs
  • Companies Mentioned: Pfizer Inc; Sanofi S.A; Teva Pharmaceutical Industries Ltd.; Aurobindo Pharma; Dr. Reddy's Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical API Manufacturing Market Characteristics

3. Pharmaceutical API Manufacturing Market Trends And Strategies

4. Pharmaceutical API Manufacturing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical API Manufacturing Market Size and Growth

  • 5.1. Global Pharmaceutical API Manufacturing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmaceutical API Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmaceutical API Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical API Manufacturing Market Segmentation

  • 6.1. Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular disorders
  • Metabolic disorders
  • Neurological disorders
  • Oncology
  • Musculoskeletal disorders
  • NSAIDs
  • Other therapeutics uses
  • 6.2. Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chemical API
  • Biological API
  • 6.3. Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription Drugs
  • Over-the-counter (OTC) Drugs

7. Pharmaceutical API Manufacturing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical API Manufacturing Market

  • 8.1. Asia-Pacific Pharmaceutical API Manufacturing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical API Manufacturing Market

  • 9.1. China Pharmaceutical API Manufacturing Market Overview
  • 9.2. China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical API Manufacturing Market

  • 10.1. India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical API Manufacturing Market

  • 11.1. Japan Pharmaceutical API Manufacturing Market Overview
  • 11.2. Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical API Manufacturing Market

  • 12.1. Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical API Manufacturing Market

  • 13.1. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical API Manufacturing Market

  • 14.1. South Korea Pharmaceutical API Manufacturing Market Overview
  • 14.2. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical API Manufacturing Market

  • 15.1. Western Europe Pharmaceutical API Manufacturing Market Overview
  • 15.2. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical API Manufacturing Market

  • 16.1. UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical API Manufacturing Market

  • 17.1. Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical API Manufacturing Market

  • 18.1. France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical API Manufacturing Market

  • 19.1. Italy Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical API Manufacturing Market

  • 20.1. Spain Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical API Manufacturing Market

  • 21.1. Eastern Europe Pharmaceutical API Manufacturing Market Overview
  • 21.2. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical API Manufacturing Market

  • 22.1. Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical API Manufacturing Market

  • 23.1. North America Pharmaceutical API Manufacturing Market Overview
  • 23.2. North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical API Manufacturing Market

  • 24.1. USA Pharmaceutical API Manufacturing Market Overview
  • 24.2. USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical API Manufacturing Market

  • 25.1. Canada Pharmaceutical API Manufacturing Market Overview
  • 25.2. Canada Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical API Manufacturing Market

  • 26.1. South America Pharmaceutical API Manufacturing Market Overview
  • 26.2. South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical API Manufacturing Market

  • 27.1. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical API Manufacturing Market

  • 28.1. Middle East Pharmaceutical API Manufacturing Market Overview
  • 28.2. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical API Manufacturing Market

  • 29.1. Africa Pharmaceutical API Manufacturing Market Overview
  • 29.2. Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical API Manufacturing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical API Manufacturing Market Competitive Landscape
  • 30.2. Pharmaceutical API Manufacturing Market Company Profiles
    • 30.2.1. Pfizer Inc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sanofi S.A
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Teva Pharmaceutical Industries Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Aurobindo Pharma
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Dr. Reddy's Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmaceutical API Manufacturing Market Other Major And Innovative Companies

  • 31.1. BASF SE
  • 31.2. Sun Pharmaceutical Industries Ltd
  • 31.3. Novartis AG
  • 31.4. Lupin Ltd
  • 31.5. Cipla Inc.
  • 31.6. Arlak Biotech
  • 31.7. Healthkind Labs Pvt. Ltd
  • 31.8. SwisscheM Healthcare Pvt. Ltd
  • 31.9. Apikos Pharma
  • 31.10. Kolaz Biotech
  • 31.11. CStone Pharma
  • 31.12. CARsgen Therapeutics
  • 31.13. JW Therapeutics
  • 31.14. BeiGene
  • 31.15. Takeda Pharmaceuticals

32. Global Pharmaceutical API Manufacturing Market Competitive Benchmarking

33. Global Pharmaceutical API Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical API Manufacturing Market

35. Pharmaceutical API Manufacturing Market Future Outlook and Potential Analysis

  • 35.1 Pharmaceutical API Manufacturing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical API Manufacturing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical API Manufacturing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제